Literature DB >> 30818992

Caution Against Overinterpreting Opiate Receptor Stimulation as Mediating Antidepressant Effects of Ketamine.

Gerard Sanacora1.   

Abstract

Entities:  

Year:  2019        PMID： 30818992     DOI： 10.1176/appi.ajp.2018.18091061

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  11 in total

Review 1.  Ketamine: The final frontier or another depressing end?

Authors:  Omar K Sial; Eric M Parise; Lyonna F Parise; Tamara Gnecco; Carlos A Bolaños-Guzmán
Journal:  Behav Brain Res       Date:  2020-02-01       Impact factor: 3.332

Review 2.  Mechanisms of ketamine and its metabolites as antidepressants.

Authors:  Evan M Hess; Lace M Riggs; Michael Michaelides; Todd D Gould
Journal:  Biochem Pharmacol       Date:  2021-12-27       Impact factor: 5.858

3.  Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents.

Authors:  Matthew E Klein; Joshua Chandra; Salma Sheriff; Roberto Malinow
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-15       Impact factor: 11.205

Review 4.  "Novel Psychopharmacology for Depressive Disorders".

Authors:  Michele Fornaro; Domenico De Berardis; Annalisa Anastasia; Andrea Fusco
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Opioid Receptor μ-1 and Ketamine Effects in a Suicidal Depression Trial: A Post Hoc Exploration.

Authors:  Michael F Grunebaum; Hanga C Galfalvy; Jun Liu; Yung-Yu Huang; Stephen Marcott; Ainsley K Burke; J John Mann
Journal:  J Clin Psychopharmacol       Date:  2020 Jul/Aug       Impact factor: 3.118

Review 6.  Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.

Authors:  Kenji Hashimoto
Journal:  Psychiatry Clin Neurosci       Date:  2019-07-11       Impact factor: 5.188

7.  Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials.

Authors:  Ziad Saad; Derrek Hibar; Maggie Fedgchin; Vanina Popova; Maura L Furey; Jaskaran B Singh; Hartmuth Kolb; Wayne C Drevets; Guang Chen
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-03       Impact factor: 5.176

8.  Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin.

Authors:  Chadi G Abdallah; Lynnette A Averill; Ralitza Gueorguieva; Selin Goktas; Prerana Purohit; Mohini Ranganathan; Mohamed Sherif; Kyung-Heup Ahn; Deepak Cyril D'Souza; Richard Formica; Steven M Southwick; Ronald S Duman; Gerard Sanacora; John H Krystal
Journal:  Neuropsychopharmacology       Date:  2020-02-24       Impact factor: 7.853

Review 9.  [The next psychoactive drugs: From imipramine to ketamine].

Authors:  P Carrillo; A-C Petit; R Gaillard; F Vinckier
Journal:  Bull Acad Natl Med       Date:  2020-09-17       Impact factor: 0.144

10.  Ketamine: A tale of two enantiomers.

Authors:  Luke A Jelen; Allan H Young; James M Stone
Journal:  J Psychopharmacol       Date:  2020-11-06       Impact factor: 4.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.